Page last updated: 2024-12-06

5-aminopyrazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-aminopyrazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74561
CHEMBL ID3217770
MeSH IDM000614085

Synonyms (69)

Synonym
AC-4837
5-aminopyrazole
EN300-27598
BB 0241798
BB 0219775
3-amino-1h-pyrazole
3-aminopyrazole
1h-pyrazol-3-amine
1820-80-0
nsc76122
nsc-76122
inchi=1/c3h5n3/c4-3-1-2-5-6-3/h1-2h,(h3,4,5,6
1h-pyrazol-5-amine
STK292780
3-aminopyrazole, 98%
A1859
AKOS000163955
916420-28-5
AKOS002657057
aminopyrazole
5-amino-pyrazole
5-amino-1h-pyrazole
BBL008564
1h-pyrazol-3-ylamine
3-pyrazolamine
pyrazol-3-ylamine
einecs 217-338-1
nsc 76122
1h-pyrazole-5-amine
114024-26-9
1h-pyrazolamine
FT-0600489
FT-0649846
AM20090067
PB32063
CHEMBL3217770
1225387-53-0
J-504716
J-504718
J-504847
amino pyrazole
3-amino pyrazole
3-amino-2h-pyrazole
2h-pyrazol-3-ylamine
3-amino-pyrazole
3-aminopyrazol
1h-pyrazole-3-amine
3-amino-1h-pyrazol
amino-pyrazole
1h-5-pyrazolamine
STR03100
3-aminopyrazole hydrochloride
Q-101973
PS-9369
PS-9370
DTXSID00171229
mfcd00005236
F0001-0657
mfcd08700632
2h-pyrazole-3-ylamine
CS-D1141
BCP27171
1h-pyrazole-imine
AMY23077
1-h-pyrazol-5-amine
Q27453670
SY128689
Z240126818
BTB7URA7K8

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Compound 6 (BKI 1708) was found to be efficacious at 8 mg/kg dosed once daily (QD) for 5 days with no observable signs of toxicity up to 200 mg/kg dosed QD for 7 days."( Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Arnold, SLM; Barrett, LK; Choi, R; Fan, E; Hackman, RC; Huang, W; Hulverson, MA; McCloskey, MC; Ojo, KK; Rivas, KL; Van Voorhis, WC; Whitman, GR; Zhang, Z, 2019
)
0.87
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.00)18.7374
1990's0 (0.00)18.2507
2000's7 (17.50)29.6817
2010's22 (55.00)24.3611
2020's9 (22.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.58 (24.57)
Research Supply Index3.76 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]